KLRS (Kalaris Therapeutics) Float Percentage Of Total Shares Outstanding: 34.99% (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KLRS Kalaris Therapeutics Inc KLRS
12 GF Score
Price $3.97
View Full Analysis

What is Kalaris Therapeutics Float Percentage Of Total Shares Outstanding?

Kalaris Therapeutics KLRS +0.76% 12 Float Percentage Of Total Shares Outstanding is 34.99% as of Aug. 11, 2026. GuruFocus rates KLRS with a GF Score™ of 12/100.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kalaris Therapeutics's float shares is 8.32 Mil. Kalaris Therapeutics's total shares outstanding is 23.79 Mil. Kalaris Therapeutics's float percentage of total shares outstanding is 34.99%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kalaris Therapeutics's Insider Ownership is 0.01%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kalaris Therapeutics's Institutional Ownership is 78.32%.

KLRS
12GF Score
Kalaris Therapeutics Inc KLRS
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kalaris Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Kalaris Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=8.32/23.79
=34.99%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 34.99% mean?
Kalaris Therapeutics (KLRS) has a Float Percentage Of Total Shares Outstanding of 34.99% as of Aug. 11, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Kalaris Therapeutics and its competitors.
Is Kalaris Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Kalaris Therapeutics' current Float Percentage Of Total Shares Outstanding is 34.99%. Overall, Kalaris Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Kalaris Therapeutics' Float Percentage Of Total Shares Outstanding compare to HRTX and VRCA?
Kalaris Therapeutics' Float Percentage Of Total Shares Outstanding of 34.99% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Kalaris Therapeutics and its competitors. Kalaris Therapeutics's current Float Percentage Of Total Shares Outstanding is 34.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kalaris Therapeutics stock overvalued right now?
Kalaris Therapeutics (KLRS) has a current Float Percentage Of Total Shares Outstanding of 34.99%. The current Float Percentage Of Total Shares Outstanding is 34.99%. Kalaris Therapeutics' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Kalaris Therapeutics (KLRS), the current Float Percentage Of Total Shares Outstanding is 34.99% as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kalaris Therapeutics Business Description

Address 400 Connell Drive, Suite 5500, Berkeley Heights, NJ, USA, 07922
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
12GF Score

Get the complete analysis for KLRS

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.97
Price